Tulrampator
Tulrampator
Tulrampator (pronounced: tu-lram-pa-tor), also known as CX-1632, is a drug that acts as an ampakine, which is a type of nootropic agent. It is designed to enhance attention span and alertness, and to facilitate learning and memory.
Etymology
The name "Tulrampator" is derived from the chemical structure of the drug. The prefix "Tul-" is an abbreviation of the chemical group tulamide, and "-rampator" is a suffix commonly used in the naming of drugs that act as agonists or antagonists at receptor sites.
Pharmacology
Tulrampator is a positive allosteric modulator of the AMPA receptor, a type of glutamate receptor that is important for synaptic plasticity, a cellular mechanism for learning and memory. By enhancing the activity of these receptors, Tulrampator is thought to improve cognitive function.
Clinical Use
Tulrampator has been investigated for use in a number of cognitive disorders, including Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), and schizophrenia. However, as of now, it is not approved for any therapeutic use by the Food and Drug Administration (FDA).
Related Terms
- Ampakine
- Nootropic
- AMPA receptor
- Alzheimer's disease
- Attention deficit hyperactivity disorder
- Schizophrenia
- Food and Drug Administration
External links
- Medical encyclopedia article on Tulrampator
- Wikipedia's article - Tulrampator
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski